Posts Tagged ‘stem cell supplement’

American Doctor Shows Age is No Barrier

Sunday, August 26th, 2012

Life Less Ordinary: Dr Walt Failor is right at home at Wairarapa Hospital.

At an age when many doctors are retiring to spend more time on the golf course, Walt Failor is just starting his new career in our home town, Masterton, New Zealand, and the Hospital where Maree worked for over 10 years.

The 63-year-old graduate doctor already has a lifetime of extraordinary experiences under his belt, and he’s now gone halfway round the world to work at Wairarapa Hospital, New Zealand.

American first-year house surgeon Dr Failor is working alongside colleagues younger than his own children and loving every minute of it.

“It’s amazing. I’m around talented people. When you have that opportunity you gain from it.”

Previously trained as a chiropractor, Dr Failor began his medical degree at the University of Health Sciences in Antigua when in his mid-50s.

In his third year of study, Dr Failor travelled around United States hospitals on training rotations, and through sheer persistence he procured a rotation at world famous Cook County Hospital in Chicago.

Determined to prove his competence, he volunteered for a six-week rotation at Cook County juvenile detention facility, performing HIV and STI checks on gang members and youth offenders.

His willing attitude earned him further work experience at the hospital.

He said on a trauma rotation he saw 27 gunshots in one night. “I’m more familiar with gunshots than a runny nose.”

But becoming a doctor is only part of his colourful career history. Dr Failor has been a reserve deputy sheriff, All-American footballer, pilot, commercial fisherman, chiropractor, hunter, shop worker and logging crew member.

He has clung to a tree for two days in Alaska while a brown bear circled the base, taken a childhood fishing trip with Senator Robert F Kennedy, and played on a college football team with O.J. Simpson.

He said at that time, University of Southern California Trojans teammate Simpson was “a great guy”. “It’s a dubious distinction now I realise but in college he had no peer. He’s the best player I’ve ever seen.”

Dr Failor was born in Aberdeen, Washington, where his father owned a sporting goods store but also became mayor of Aberdeen when his children were young.

In high school Dr Failor excelled at football and baseball, earning a place on the All-American football team and being drafted into the New York Yankees baseball team. However, his father decided he should go to college, so he didn’t tell him he had been drafted until years later.

After completing a degree in business and athletics, Dr Failor spent some time in Aberdeen working at his father’s store and patrolling beaches as a reserve deputy sheriff.

Deciding it was not his “cup of tea”, he left Aberdeen to train as a chiropractor in the American Midwest.

Upon his graduation in 1982 Dr Failor moved to Alaska to set up a practice and spent more than a decade there commercial fishing, dodging brown bears and flying Piper aircraft.

He arrived in Masterton in September 2011, fresh from driving a long-haul truck across the US to pay for his airfare to New Zealand.

Dr Failor said he chose New Zealand as a graduate job destination because he preferred the style of the entrance exams to that of other countries.

Before coming here, his only exposure to Kiwis was through 1972 All Black Duncan Hales who coached his chiropractic school rugby team to win the national championships in the 1970s.

He said Masterton reminded him of his home town Aberdeen for both its size and lifestyle. “Coming here is the best decision I made.”

Dr Failor would like to become a consultant in emergency medicine – a qualification he will reach by the time he is 68.

Adult Stem Cells Show Greatest Promise

Wednesday, July 18th, 2012

Chuck Donovan President of the Charlotte Lozier Institute

Washington D.C., Jul 17, 2012 / 04:04 am (CNA/EWTN News).- A new report on one of the world’s largest funders of stem cell research reveals that an emphasis on results has led to a shift in funding towards morally-acceptable work with adult stem cells.

In the field of stem cell research, the “predominant progress” is being made by non-controversial adult stem cells, said Chuck Donovan, president of the Charlotte Lozier Institute, which serves as the education and research arm of pro-life Susan B. Anthony List.

Donovan told CNA on July 16 that an analysis of scientific funding over several years suggests that morally acceptable types of stem cell research offer the greatest promise for a wide variety of effective therapies and treatments.

Research on adult stem cells does not require the destruction of a human embryo and therefore does not pose the ethical difficulties associated with embryonic stem cell research. In addition, adult stem cell research has already contributed to advancing therapies for various diseases.

On July 12, the Lozier Institute released a report titled “The Ethical Stems of Good Science,” which examined changes in the funding offered by the California Institute for Regenerative Medicine since 2007.

The California institute was created after President George W. Bush announced in 2001 that his administration would become the first to provide federal funding for human embryonic stem cell research, although this funding was limited to stem cell lines that had already been developed.

Dissatisfied with the limits put in place by the president, California established its own Institute for Regenerative Medicine to distribute $3 billion to stem cell research efforts, with a particular emphasis on human embryonic stem cells and other types of research that received limited or no federal funding.

One calculation found that the institute was “the largest funder of overall stem cell research in the world” from 2007, when it first began issuing grants, to February 2011.

According to the recent Lozier report, the California institute funded more than 100 projects in 2007 involving embryonic research and cloning, while giving virtually no funding to adult or other non-embryonic avenues of stem cell research.

In the years that followed, however, the organization’s grants increasingly went to fund projects using non-controversial forms of research.

A new category of grants in 2009 was specifically awarded to projects with “the best chance of resulting in clinical trials,” the report observed. Of these grants, only four went to human embryonic stem cell research, while the remaining 10 went to non-embryonic types of research.

This trend has continued every year since 2009, the report found. As grants are awarded “based on their potential to prove therapeutically beneficial,” non-embryonic research receives far more support than embryonic research.

The failure of embryonic stem cell research to yield therapeutic results has also led private investors to put their money elsewhere. Last November, the biopharmecuetical company Geron announced that it had ended a widely publicized embryonic stem cell research study due to “capital scarcity.”

Donovan said that the shift in funding based on results is logical.

In a statement released with the Lozier report, he explained that “despite the millions of dollars spent on this research, cures brought about by embryonic stem cells have continued to prove elusive, while adult stem cell research applications have exploded.”

“As the leading funder of stem cell research, the California Institute for Regenerative Medicine has made grant decisions that show where the industry sees promise,” he noted. “In the past six years, where that promise lies has become increasingly clear: ethical adult stem cell research.”